PDLIM5 and breast carcinoma: Indeed, an ectopic PDLIM5 expression in HNRNPC-deficient cells was sufficient to reduce the lung metastatic burden to the levels similar to control cells with intact HNRNPC expression (Fig. 5f), in line with HNRNPC acting upstream of PDLIM5 to control breast cancer metastasis.